CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig

Microbes and Infection

Volumn 7, Issue 7-8, 2005, Pages 1040-1048

  Vacca, Carmine ^a   Fallarino, Francesca ^a   Perruccio, Katia ^a   Orabona, Ciriana ^a   Bianchi, Roberta ^a   Gizzi, Stefania ^a   Velardi, Andrea ^a   Fioretti, Maria Cristina ^a   Puccetti, Paolo ^a   Grohmann, Ursula ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

CD40L; CTLA 4 Ig; Human dendritic cells; Tolerance

Indexed keywords

CD40 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; INDOLEAMINE 2,3 DIOXYGENASE; MEMBRANE ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE P38; TRYPTOPHAN;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; CATABOLISM; CELL ACTIVITY; CELL MATURATION; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE;

EID: 22144494179     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2005.03.030     Document Type: Short Survey

References (26)

1. G.Q. Phan, J.C. Yang, R.M. Sherry, P. Hwu, S.L. Topalian, D.J. Schwartzentruber, N.P. Restifo, L.R. Haworth, C.A. Seipp, L.J. Freezer, K.E. Morton, S.A. Mavroukakis, P.H. Duray, S.M. Steinberg, J.P. Allison, T.A. Davis, and S.A. Rosenberg Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma Proc. Natl. Acad. Sci. USA 100 2003 8372 8377
2. C.B. Thompson, and J.P. Allison The emerging role of CTLA-4 as an immune attenuator Immunity 7 1997 445 450
3. B. Salomon, and J.A. Bluestone Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation Annu. Rev. Immunol. 19 2001 225 252
4. D.J. Lenschow, Y. Zeng, J.R. Thistlethwaite, A. Montag, W. Brady, M.G. Gibson, P.S. Linsley, and J.A. Bluestone Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig Science 257 1992 789 792
5. B.K. Finck, P.S. Linsley, and D. Wofsy Treatment of murine lupus with CTLA4Ig Science 265 1994 1225 1227
6. M.H. Sayegh Finally, CTLA4Ig graduates to the clinic J. Clin. Invest. 103 1999 1223 1225
7. J.M. Kremer, R. Westhovens, M. Leon, E. Di Giorgio, R. Alten, S. Steinfeld, A. Russell, M. Dougados, P. Emery, I.F. Nuamah, G.R. Williams, J.C. Becker, D.T. Hagerty, and L.W. Moreland Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig New Engl. J. Med. 349 2003 1907 1915
8. U. Grohmann, C. Orabona, F. Fallarino, C. Vacca, F. Calcinaro, A. Falorni, P. Candeloro, M.L. Belladonna, R. Bianchi, M.C. Fioretti, and P. Puccetti CTLA-4-Ig regulates tryptophan catabolism in vivo Nat. Immunol. 3 2002 1097 1101
9. U. Grohmann, F. Fallarino, and P. Puccetti Tolerance, DCs and tryptophan: much ado about IDO Trends Immunol. 24 2003 242 248
10. F. Fallarino, U. Grohmann, K. Hwang, C. Orabona, C. Vacca, R. Bianchi, M.L. Belladonna, M.C. Fioretti, M.L. Alegre, and P. Puccetti Modulation of tryptophan catabolism by regulatory T cells Nat. Immunol. 4 2003 1206 1212
11. P. Hwu, M.X. Du, R. Lapointe, M. Do, M.W. Taylor, and M.W. Young Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation J. Immunol. 164 2000 3596 3599
12. D.H. Munn, M.D. Sharma, J.R. Lee, K.G. Jhaver, T.S. Johnson, D.B. Keskin, B. Marshall, P. Chandler, S.J. Antonia, R. Burgess, C.L. Slingluff Jr., and A.L. Mellor Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase Science 297 2002 1867 1870
13. + T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells J. Immunol. 172 2004 4100 4110
14. A. Wesa, and A. Galy Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand BMC Immunol. 3 2002 14
15. I. Volpi, K. Perruccio, A. Tosti, M. Capanni, L. Ruggeri, S. Posati, F. Aversa, A. Tabilio, L. Romani, M.F. Martelli, and A. Velardi Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants Blood 97 2001 2514 2521
16. U. Grohmann, R. Bianchi, C. Orabona, F. Fallarino, C. Vacca, A. Micheletti, and M.C. Fioretti Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation J. Immunol. 171 2003 2581 2587
17. U. Grohmann, F. Fallarino, S. Silla, R. Bianchi, M.L. Belladonna, C. Vacca, A. Micheletti, M.C. Fioretti, and P. Puccetti CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells J. Immunol. 166 2001 277 283
18. F. Fallarino, U. Grohmann, C. Vacca, R. Bianchi, C. Orabona, A. Spreca, M.C. Fioretti, and P. Puccetti T cell apoptosis by tryptophan catabolism Cell Death Differ. 9 2002 1069 1077
19. + T cells Immunity 19 2003 877 889
20. D.H. Munn, M. Zhou, J.T. Attwood, I. Bondarev, S.J. Conway, B. Marshall, C. Brown, and A.L. Mellor Prevention of allogeneic fetal rejection by tryptophan catabolism Science 281 1998 1191 1193
21. U. Grohmann, F. Fallarino, R. Bianchi, C. Orabona, C. Vacca, M.C. Fioretti, and P. Puccetti A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice J. Exp. Med. 198 2003 153 160
22. E.B. Finger, and J.A. Bluestone When ligand becomes receptor - tolerance via B7 signaling on DCs Nat. Immunol. 3 2002 1056 1057
23. T.A. Babcock, and J.M. Carlin Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor α in interferon-treated epithelial cells Cytokine 12 2000 588 594
24. S. Fujigaki, K. Saito, K. Sekikawa, S. Tone, O. Takikawa, H. Fujii, H. Wada, A. Noma, and M. Seishima Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-γ-independent mechanism Eur. J. Immunol. 31 2001 2313 2318
25. X. Wang, W. Huang, M. Mihara, J. Sinha, and A. Davidson Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus erythematosus J. Immunol. 168 2002 2046 2053
26. Y. Li, X.X. Zheng, X.C. Li, M.S. Zand, and T.B. Strom Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment Transplantation 66 1998 1387 1388